Search results
Results from the WOW.Com Content Network
Bahrain International Airport 26°16′15″N 050°38′01″E / 26.27083°N 50.63361°E / 26.27083; 50.63361 ( Bahrain International Military Airports
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [37] is an mRNA vaccine [156] produced by the German company BioNTech and the American company Pfizer. [ 156 ] [ 157 ] [ 158 ] In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by Fosun Pharma .
In January 2021, Bahrain announced the approval of a third vaccine, the Oxford–AstraZeneca COVID-19 vaccine, from Serum Institute of India, [9] [10] among the choices of vaccines that the people of Bahrain can opt for, when getting vaccinated against Covid-19. Bahrain launched the world's first vaccine appointment app, which allowed people to ...
On 21 February, Bahrain confirmed the first COVID-19 cases, a school bus driver who came from Iran via Dubai. [3] On 24 February, a Bahraini woman arriving at the Bahrain International Airport from Iran via Dubai was examined as part of the precautionary measures and tested positive for SARS-CoV-2. She had arrived from Iran with her husband and ...
The fourth Vaccine approved by Bahrain’s NHRA is Sputnik V COVID-19 vaccine. [11] The National Health Regulatory Authority (NHRA) has also authorized, as the fifth vaccine, the emergency use of Janssen COVID-19 vaccine from Johnson and Johnson. [12] Bahrain became the first country in the world to approve this particular vaccine. [13]
How COVID‑19 vaccines work. The video shows the process of vaccination, from injection with RNA or viral vector vaccines, to uptake and translation, and on to immune system stimulation and effect. Part of a series on the COVID-19 pandemic Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. COVID-19 (disease) SARS-CoV-2 (virus) Cases Deaths ...
The Janssen COVID‑19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, [1] is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, [24] and its Belgian parent company Janssen Pharmaceuticals, [25] a subsidiary of American company Johnson & Johnson.
During the COVID-19 pandemic, several COVID-19 vaccines were developed, and in December 2020 the first vaccination campaign was planned. [8] Anticipating the vaccine, on 23 November 2020, Qantas announced that the company would ask for proof of COVID-19 vaccination from international travellers. According to Alan Joyce, the firm's CEO, a ...